Human epidermal growth factor receptor 2 negative tumor

Clinical trials for Human epidermal growth factor receptor 2 negative tumor explained in plain language.

Never miss a new study

Get alerted when new Human epidermal growth factor receptor 2 negative tumor trials appear

Sign up with your email to follow new studies for Human epidermal growth factor receptor 2 negative tumor, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Gene test may spare thousands from chemo

Knowledge-focused Ongoing

This study follows over 1,100 women with early-stage, hormone-sensitive breast cancer who took the EndoPredict® gene test. Researchers want to see if those classified as 'low risk' can safely receive only hormone therapy without chemotherapy. The goal is to confirm that 10-year s…

Matched conditions: HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE TUMOR

Sponsor: North Eastern German Society of Gynaecological Oncology • Aim: Knowledge-focused

Last updated Jun 27, 2026 12:06 UTC

Human epidermal growth factor receptor 2 negative tumor

Get alerted when new Human epidermal growth factor receptor 2 negative tumor trials appear

Gene test may spare thousands from chemo